SCHEMBL6152266

SCHEMBL6152266

COc1ccc2c(c1)c(=O)c1ccccc1n2C

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 6/20 0.76
KDM4E B2RXH2 3/20 0.76
ALDH1A1 P00352 3/20 0.76
MEN1 O00255 3/20 0.76
KMT2A Q03164 3/20 0.76
HPGD P15428 2/20 0.76
MAPT P10636 2/20 0.76
HTT P42858 1/20 0.76
HSD17B10 Q99714 1/20 0.76
NTRK1 P04629 2/20 0.59
SMN1; SMN2 Q16637 1/20 0.57
NPSR1 Q6W5P4 1/20 0.57
ATM Q13315 1/20 0.54
P2RX4 Q99571 1/20 0.54
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
TDP1 Q9NUW8 1/20 0.53
ABCG2 Q9UNQ0 1/20 0.53
MAOA P21397 1/20 0.53
PTGS2 P35354 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13295998 0.90 L3MBTL1 (0.72) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL15465959 0.86 L3MBTL1 (1.00) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL6151617 0.84 L3MBTL1 (0.58) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL12692736 0.84 ALDH1A1 (0.57) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL24525575 0.84 P2RX4 (0.58) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL11382265 0.83 ALDH1A1 (0.68) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL6152494 0.83 KDM4E (0.58) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL8086565 0.83 L3MBTL1 (0.56) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL6151586 0.83 L3MBTL1 (0.56) L3MBTL1KDM4EALDH1A1MEN1KMT2A
SCHEMBL24155343 0.82 L3MBTL1 (0.52) L3MBTL1KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030044646-A1 Electroluminescent (EL) devices XEROX CORPORATION 2003-03-06 US claimed
US-6479172-B2 PERFORMANCE, THERMOSTABILITY XEROX CORPORATION 2002-11-12 US claimed
US-20020132134-A1 Electroluminescent (EL) devices XEROX CORPORATION 2002-09-19 US claimed
EP-3109703-B1 PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, AND METHOD FOR FORMING PATTERN USING SAME TOKYO ELECTRON LTD (JP) 2020-12-30 EP disclosed
US-10025187-B2 Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting TOKYO ELECTRON LIMITED (JP) 2018-07-17 US disclosed
US-10025187-B2 Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting TOKYO ELECTRON LIMITED (JP) 2018-07-17 US disclosed
US-10018911-B2 Chemically amplified resist material and resist pattern-forming method JSR CORPORATION (JP) 2018-07-10 US disclosed
US-10018911-B2 Chemically amplified resist material and resist pattern-forming method JSR CORPORATION (JP) 2018-07-10 US disclosed
US-9971247-B2 Pattern-forming method OSAKA UNIVERSITY (JP) 2018-05-15 US disclosed
US-9971247-B2 Pattern-forming method OSAKA UNIVERSITY (JP) 2018-05-15 US disclosed
EP-2597128-B1 Novel blue emitters for use in organic electroluminescence devices LG DISPLAY CO LTD (KR) 2017-07-05 EP disclosed
US-20070194692-A1 Light emitting element and light emitting device having the light emittig element SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-08-23 US disclosed
US-7169482-B2 Display device with anthracene and triazine derivatives LG.PHILIPS LCD CO., LTD. (KR) 2007-01-30 US disclosed
US-7169482-B2 Display device with anthracene and triazine derivatives LG.PHILIPS LCD CO., LTD. (KR) 2007-01-30 US disclosed
EP-1580250-A2 Novel blue emitters for use in organic electroluminescence devices Xerox Corporation (US) 2005-09-28 EP disclosed
US-20050175857-A1 Element including fluorescent 1,1'-binaphthyl derivative; uniform luminescence, saturated color; thermal stability; performance; vacuum deposition thin films; enhanced charge transporting, reduced driving voltage XEROX CORPORATION (US) 2005-08-11 US disclosed
US-6562485-B2 Electroluminescent (EL) devices XEROX CORPORATION 2003-05-13 US disclosed
US-20030044646-A1 Electroluminescent (EL) devices XEROX CORPORATION 2003-03-06 US disclosed
US-6479172-B2 PERFORMANCE, THERMOSTABILITY XEROX CORPORATION 2002-11-12 US disclosed
US-20020132134-A1 Electroluminescent (EL) devices XEROX CORPORATION 2002-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10025187-B2 Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting ASIC1, ASIC3, CLTA L3MBTL1 3448/4885KDM4E 3345/4885ALDH1A1 1963/4885
US-10018911-B2 Chemically amplified resist material and resist pattern-forming method SLC11A2, XRCC5, RAD54L L3MBTL1 4063/4885KDM4E 4396/4885ALDH1A1 2183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.